Global CAR-T Therapy for Hematological Cancer Market Growth (Status and Outlook) 2026-2032
The global CAR-T Therapy for Hematological Cancer market size is predicted to grow from US$ 6539 million in 2025 to US$ 33810 million in 2032; it is expected to grow at a CAGR of 27.0% from 2026 to 2032.
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a cutting-edge immunotherapy for hematological cancers, involving the genetic modification of a patient?s T cells to express synthetic receptors targeting specific antigens on cancer cells. These engineered T cells are expanded in the lab and reintroduced into the patient, where they can recognize and destroy cancerous cells with high specificity. Key features include its remarkable efficacy in treating certain blood cancers like B-cell lymphomas, leukemias, and multiple myeloma, particularly in patients with relapsed or refractory disease, and its potential for long-term remission. CAR-T therapy is primarily applied in advanced hematological malignancies and is being explored for broader indications through ongoing clinical trials. Despite its promise, challenges such as high cost, manufacturing complexity, and management of severe side effects like cytokine release syndrome (CRS) remain areas of active research.
United States market for CAR-T Therapy for Hematological Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CAR-T Therapy for Hematological Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CAR-T Therapy for Hematological Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CAR-T Therapy for Hematological Cancer players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, J&J, JW Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?CAR-T Therapy for Hematological Cancer Industry Forecast? looks at past sales and reviews total world CAR-T Therapy for Hematological Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Therapy for Hematological Cancer sales for 2026 through 2032. With CAR-T Therapy for Hematological Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Therapy for Hematological Cancer industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Therapy for Hematological Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Therapy for Hematological Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CAR-T Therapy for Hematological Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Therapy for Hematological Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Therapy for Hematological Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Therapy for Hematological Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a cutting-edge immunotherapy for hematological cancers, involving the genetic modification of a patient?s T cells to express synthetic receptors targeting specific antigens on cancer cells. These engineered T cells are expanded in the lab and reintroduced into the patient, where they can recognize and destroy cancerous cells with high specificity. Key features include its remarkable efficacy in treating certain blood cancers like B-cell lymphomas, leukemias, and multiple myeloma, particularly in patients with relapsed or refractory disease, and its potential for long-term remission. CAR-T therapy is primarily applied in advanced hematological malignancies and is being explored for broader indications through ongoing clinical trials. Despite its promise, challenges such as high cost, manufacturing complexity, and management of severe side effects like cytokine release syndrome (CRS) remain areas of active research.
United States market for CAR-T Therapy for Hematological Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for CAR-T Therapy for Hematological Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for CAR-T Therapy for Hematological Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key CAR-T Therapy for Hematological Cancer players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, J&J, JW Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?CAR-T Therapy for Hematological Cancer Industry Forecast? looks at past sales and reviews total world CAR-T Therapy for Hematological Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Therapy for Hematological Cancer sales for 2026 through 2032. With CAR-T Therapy for Hematological Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Therapy for Hematological Cancer industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Therapy for Hematological Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Therapy for Hematological Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CAR-T Therapy for Hematological Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Therapy for Hematological Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Therapy for Hematological Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Therapy for Hematological Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Target: CD19
- Target: BCMA
- Others
- Lymphoma
- Multiple Myeloma
- Leukemia
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J&J
- JW Therapeutics
- FOSUNKite
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Therapy for Hematological Cancer Market Size (2021-2032)
2.1.2 CAR-T Therapy for Hematological Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-T Therapy for Hematological Cancer by Country/Region (2021, 2025 & 2032)
2.2 CAR-T Therapy for Hematological Cancer Segment by Type
2.2.1 Target: CD19
2.2.2 Target: BCMA
2.2.3 Others
2.2.4 CAR-T Therapy for Hematological Cancer Market Size by Type
2.2.4.1 CAR-T Therapy for Hematological Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
2.3 CAR-T Therapy for Hematological Cancer Segment by Application
2.3.1 Lymphoma
2.3.2 Multiple Myeloma
2.3.3 Leukemia
2.3.4 CAR-T Therapy for Hematological Cancer Market Size by Application
2.3.4.1 CAR-T Therapy for Hematological Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
3 CAR-T THERAPY FOR HEMATOLOGICAL CANCER MARKET SIZE BY PLAYER
3.1 CAR-T Therapy for Hematological Cancer Market Size Market Share by Player
3.1.1 Global CAR-T Therapy for Hematological Cancer Revenue by Player (2021-2026)
3.1.2 Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Player (2021-2026)
3.2 Global CAR-T Therapy for Hematological Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T THERAPY FOR HEMATOLOGICAL CANCER BY REGION
4.1 CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026)
4.2 Global CAR-T Therapy for Hematological Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
4.4 APAC CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
4.5 Europe CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026)
5.2 Americas CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
5.3 Americas CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026)
6.2 APAC CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
6.3 APAC CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026)
7.2 Europe CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
7.3 Europe CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Therapy for Hematological Cancer by Region (2021-2026)
8.2 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-T THERAPY FOR HEMATOLOGICAL CANCER MARKET FORECAST
10.1 Global CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.1.1 Global CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.1.2 Americas CAR-T Therapy for Hematological Cancer Forecast
10.1.3 APAC CAR-T Therapy for Hematological Cancer Forecast
10.1.4 Europe CAR-T Therapy for Hematological Cancer Forecast
10.1.5 Middle East & Africa CAR-T Therapy for Hematological Cancer Forecast
10.2 Americas CAR-T Therapy for Hematological Cancer Forecast by Country (2027-2032)
10.2.1 United States Market CAR-T Therapy for Hematological Cancer Forecast
10.2.2 Canada Market CAR-T Therapy for Hematological Cancer Forecast
10.2.3 Mexico Market CAR-T Therapy for Hematological Cancer Forecast
10.2.4 Brazil Market CAR-T Therapy for Hematological Cancer Forecast
10.3 APAC CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.3.1 China CAR-T Therapy for Hematological Cancer Market Forecast
10.3.2 Japan Market CAR-T Therapy for Hematological Cancer Forecast
10.3.3 Korea Market CAR-T Therapy for Hematological Cancer Forecast
10.3.4 Southeast Asia Market CAR-T Therapy for Hematological Cancer Forecast
10.3.5 India Market CAR-T Therapy for Hematological Cancer Forecast
10.3.6 Australia Market CAR-T Therapy for Hematological Cancer Forecast
10.4 Europe CAR-T Therapy for Hematological Cancer Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-T Therapy for Hematological Cancer Forecast
10.4.2 France Market CAR-T Therapy for Hematological Cancer Forecast
10.4.3 UK Market CAR-T Therapy for Hematological Cancer Forecast
10.4.4 Italy Market CAR-T Therapy for Hematological Cancer Forecast
10.4.5 Russia Market CAR-T Therapy for Hematological Cancer Forecast
10.5 Middle East & Africa CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-T Therapy for Hematological Cancer Forecast
10.5.2 South Africa Market CAR-T Therapy for Hematological Cancer Forecast
10.5.3 Israel Market CAR-T Therapy for Hematological Cancer Forecast
10.5.4 Turkey Market CAR-T Therapy for Hematological Cancer Forecast
10.6 Global CAR-T Therapy for Hematological Cancer Forecast by Type (2027-2032)
10.7 Global CAR-T Therapy for Hematological Cancer Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-T Therapy for Hematological Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR-T Therapy for Hematological Cancer Product Offered
11.1.3 Novartis CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR-T Therapy for Hematological Cancer Product Offered
11.2.3 Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Product Offered
11.3.3 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J&J
11.4.1 J&J Company Information
11.4.2 J&J CAR-T Therapy for Hematological Cancer Product Offered
11.4.3 J&J CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 J&J Main Business Overview
11.4.5 J&J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR-T Therapy for Hematological Cancer Product Offered
11.5.3 JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR-T Therapy for Hematological Cancer Product Offered
11.6.3 FOSUNKite CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Therapy for Hematological Cancer Market Size (2021-2032)
2.1.2 CAR-T Therapy for Hematological Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-T Therapy for Hematological Cancer by Country/Region (2021, 2025 & 2032)
2.2 CAR-T Therapy for Hematological Cancer Segment by Type
2.2.1 Target: CD19
2.2.2 Target: BCMA
2.2.3 Others
2.2.4 CAR-T Therapy for Hematological Cancer Market Size by Type
2.2.4.1 CAR-T Therapy for Hematological Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
2.3 CAR-T Therapy for Hematological Cancer Segment by Application
2.3.1 Lymphoma
2.3.2 Multiple Myeloma
2.3.3 Leukemia
2.3.4 CAR-T Therapy for Hematological Cancer Market Size by Application
2.3.4.1 CAR-T Therapy for Hematological Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
3 CAR-T THERAPY FOR HEMATOLOGICAL CANCER MARKET SIZE BY PLAYER
3.1 CAR-T Therapy for Hematological Cancer Market Size Market Share by Player
3.1.1 Global CAR-T Therapy for Hematological Cancer Revenue by Player (2021-2026)
3.1.2 Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Player (2021-2026)
3.2 Global CAR-T Therapy for Hematological Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T THERAPY FOR HEMATOLOGICAL CANCER BY REGION
4.1 CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026)
4.2 Global CAR-T Therapy for Hematological Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
4.4 APAC CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
4.5 Europe CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026)
5.2 Americas CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
5.3 Americas CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026)
6.2 APAC CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
6.3 APAC CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026)
7.2 Europe CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
7.3 Europe CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Therapy for Hematological Cancer by Region (2021-2026)
8.2 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-T THERAPY FOR HEMATOLOGICAL CANCER MARKET FORECAST
10.1 Global CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.1.1 Global CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.1.2 Americas CAR-T Therapy for Hematological Cancer Forecast
10.1.3 APAC CAR-T Therapy for Hematological Cancer Forecast
10.1.4 Europe CAR-T Therapy for Hematological Cancer Forecast
10.1.5 Middle East & Africa CAR-T Therapy for Hematological Cancer Forecast
10.2 Americas CAR-T Therapy for Hematological Cancer Forecast by Country (2027-2032)
10.2.1 United States Market CAR-T Therapy for Hematological Cancer Forecast
10.2.2 Canada Market CAR-T Therapy for Hematological Cancer Forecast
10.2.3 Mexico Market CAR-T Therapy for Hematological Cancer Forecast
10.2.4 Brazil Market CAR-T Therapy for Hematological Cancer Forecast
10.3 APAC CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.3.1 China CAR-T Therapy for Hematological Cancer Market Forecast
10.3.2 Japan Market CAR-T Therapy for Hematological Cancer Forecast
10.3.3 Korea Market CAR-T Therapy for Hematological Cancer Forecast
10.3.4 Southeast Asia Market CAR-T Therapy for Hematological Cancer Forecast
10.3.5 India Market CAR-T Therapy for Hematological Cancer Forecast
10.3.6 Australia Market CAR-T Therapy for Hematological Cancer Forecast
10.4 Europe CAR-T Therapy for Hematological Cancer Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-T Therapy for Hematological Cancer Forecast
10.4.2 France Market CAR-T Therapy for Hematological Cancer Forecast
10.4.3 UK Market CAR-T Therapy for Hematological Cancer Forecast
10.4.4 Italy Market CAR-T Therapy for Hematological Cancer Forecast
10.4.5 Russia Market CAR-T Therapy for Hematological Cancer Forecast
10.5 Middle East & Africa CAR-T Therapy for Hematological Cancer Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-T Therapy for Hematological Cancer Forecast
10.5.2 South Africa Market CAR-T Therapy for Hematological Cancer Forecast
10.5.3 Israel Market CAR-T Therapy for Hematological Cancer Forecast
10.5.4 Turkey Market CAR-T Therapy for Hematological Cancer Forecast
10.6 Global CAR-T Therapy for Hematological Cancer Forecast by Type (2027-2032)
10.7 Global CAR-T Therapy for Hematological Cancer Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-T Therapy for Hematological Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR-T Therapy for Hematological Cancer Product Offered
11.1.3 Novartis CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR-T Therapy for Hematological Cancer Product Offered
11.2.3 Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Product Offered
11.3.3 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J&J
11.4.1 J&J Company Information
11.4.2 J&J CAR-T Therapy for Hematological Cancer Product Offered
11.4.3 J&J CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 J&J Main Business Overview
11.4.5 J&J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR-T Therapy for Hematological Cancer Product Offered
11.5.3 JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR-T Therapy for Hematological Cancer Product Offered
11.6.3 FOSUNKite CAR-T Therapy for Hematological Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR-T Therapy for Hematological Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-T Therapy for Hematological Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Target: CD19
Table 4. Major Players of Target: BCMA
Table 5. Major Players of Others
Table 6. CAR-T Therapy for Hematological Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 8. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Table 9. CAR-T Therapy for Hematological Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 11. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Table 12. Global CAR-T Therapy for Hematological Cancer Revenue by Player (2021-2026) & ($ millions)
Table 13. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Player (2021-2026)
Table 14. CAR-T Therapy for Hematological Cancer Key Players Head office and Products Offered
Table 15. CAR-T Therapy for Hematological Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026) & ($ millions)
Table 19. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Table 20. Global CAR-T Therapy for Hematological Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas CAR-T Therapy for Hematological Cancer Market Size Market Share by Country (2021-2026)
Table 24. Americas CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Table 26. Americas CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Table 28. APAC CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Table 30. APAC CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Country (2021-2026)
Table 34. Europe CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CAR-T Therapy for Hematological Cancer
Table 40. Key Market Challenges & Risks of CAR-T Therapy for Hematological Cancer
Table 41. Key Industry Trends of CAR-T Therapy for Hematological Cancer
Table 42. Global CAR-T Therapy for Hematological Cancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global CAR-T Therapy for Hematological Cancer Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global CAR-T Therapy for Hematological Cancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global CAR-T Therapy for Hematological Cancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Novartis Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 47. Novartis CAR-T Therapy for Hematological Cancer Product Offered
Table 48. Novartis CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Novartis Main Business
Table 50. Novartis Latest Developments
Table 51. Gilead Sciences Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 52. Gilead Sciences CAR-T Therapy for Hematological Cancer Product Offered
Table 53. Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Gilead Sciences Main Business
Table 55. Gilead Sciences Latest Developments
Table 56. Bristol-Myers Squibb Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 57. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Product Offered
Table 58. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Bristol-Myers Squibb Main Business
Table 60. Bristol-Myers Squibb Latest Developments
Table 61. J&J Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 62. J&J CAR-T Therapy for Hematological Cancer Product Offered
Table 63. J&J CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. J&J Main Business
Table 65. J&J Latest Developments
Table 66. JW Therapeutics Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 67. JW Therapeutics CAR-T Therapy for Hematological Cancer Product Offered
Table 68. JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. JW Therapeutics Main Business
Table 70. JW Therapeutics Latest Developments
Table 71. FOSUNKite Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 72. FOSUNKite CAR-T Therapy for Hematological Cancer Product Offered
Table 73. FOSUNKite CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. FOSUNKite Main Business
Table 75. FOSUNKite Latest Developments
Table 1. CAR-T Therapy for Hematological Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-T Therapy for Hematological Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Target: CD19
Table 4. Major Players of Target: BCMA
Table 5. Major Players of Others
Table 6. CAR-T Therapy for Hematological Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 8. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Table 9. CAR-T Therapy for Hematological Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 11. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Table 12. Global CAR-T Therapy for Hematological Cancer Revenue by Player (2021-2026) & ($ millions)
Table 13. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Player (2021-2026)
Table 14. CAR-T Therapy for Hematological Cancer Key Players Head office and Products Offered
Table 15. CAR-T Therapy for Hematological Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026) & ($ millions)
Table 19. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Table 20. Global CAR-T Therapy for Hematological Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas CAR-T Therapy for Hematological Cancer Market Size Market Share by Country (2021-2026)
Table 24. Americas CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Table 26. Americas CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Table 28. APAC CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Table 30. APAC CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Country (2021-2026)
Table 34. Europe CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CAR-T Therapy for Hematological Cancer
Table 40. Key Market Challenges & Risks of CAR-T Therapy for Hematological Cancer
Table 41. Key Industry Trends of CAR-T Therapy for Hematological Cancer
Table 42. Global CAR-T Therapy for Hematological Cancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global CAR-T Therapy for Hematological Cancer Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global CAR-T Therapy for Hematological Cancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global CAR-T Therapy for Hematological Cancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Novartis Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 47. Novartis CAR-T Therapy for Hematological Cancer Product Offered
Table 48. Novartis CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Novartis Main Business
Table 50. Novartis Latest Developments
Table 51. Gilead Sciences Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 52. Gilead Sciences CAR-T Therapy for Hematological Cancer Product Offered
Table 53. Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Gilead Sciences Main Business
Table 55. Gilead Sciences Latest Developments
Table 56. Bristol-Myers Squibb Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 57. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Product Offered
Table 58. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Bristol-Myers Squibb Main Business
Table 60. Bristol-Myers Squibb Latest Developments
Table 61. J&J Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 62. J&J CAR-T Therapy for Hematological Cancer Product Offered
Table 63. J&J CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. J&J Main Business
Table 65. J&J Latest Developments
Table 66. JW Therapeutics Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 67. JW Therapeutics CAR-T Therapy for Hematological Cancer Product Offered
Table 68. JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. JW Therapeutics Main Business
Table 70. JW Therapeutics Latest Developments
Table 71. FOSUNKite Details, Company Type, CAR-T Therapy for Hematological Cancer Area Served and Its Competitors
Table 72. FOSUNKite CAR-T Therapy for Hematological Cancer Product Offered
Table 73. FOSUNKite CAR-T Therapy for Hematological Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. FOSUNKite Main Business
Table 75. FOSUNKite Latest Developments
LIST OF FIGURES
Figure 1. CAR-T Therapy for Hematological Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Therapy for Hematological Cancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-T Therapy for Hematological Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-T Therapy for Hematological Cancer Sales Market Share by Country/Region (2025)
Figure 8. CAR-T Therapy for Hematological Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Type in 2025
Figure 10. CAR-T Therapy for Hematological Cancer in Lymphoma
Figure 11. Global CAR-T Therapy for Hematological Cancer Market: Lymphoma (2021-2026) & ($ millions)
Figure 12. CAR-T Therapy for Hematological Cancer in Multiple Myeloma
Figure 13. Global CAR-T Therapy for Hematological Cancer Market: Multiple Myeloma (2021-2026) & ($ millions)
Figure 14. CAR-T Therapy for Hematological Cancer in Leukemia
Figure 15. Global CAR-T Therapy for Hematological Cancer Market: Leukemia (2021-2026) & ($ millions)
Figure 16. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Application in 2025
Figure 17. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Player in 2025
Figure 18. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Figure 19. Americas CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 20. APAC CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 21. Europe CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 23. Americas CAR-T Therapy for Hematological Cancer Value Market Share by Country in 2025
Figure 24. United States CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Region in 2025
Figure 29. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Figure 30. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Figure 31. China CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 35. India CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Country in 2025
Figure 38. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Figure 39. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Figure 40. Germany CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 41. France CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 42. UK CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Figure 48. Egypt CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 54. APAC CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 55. Europe CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 57. United States CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 58. Canada CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 59. Mexico CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 60. Brazil CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 61. China CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 62. Japan CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 63. Korea CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 65. India CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 66. Australia CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 67. Germany CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 68. France CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 69. UK CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 70. Italy CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 71. Russia CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 72. Egypt CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 73. South Africa CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 74. Israel CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 75. Turkey CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 76. Global CAR-T Therapy for Hematological Cancer Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global CAR-T Therapy for Hematological Cancer Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 1. CAR-T Therapy for Hematological Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Therapy for Hematological Cancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-T Therapy for Hematological Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-T Therapy for Hematological Cancer Sales Market Share by Country/Region (2025)
Figure 8. CAR-T Therapy for Hematological Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Type in 2025
Figure 10. CAR-T Therapy for Hematological Cancer in Lymphoma
Figure 11. Global CAR-T Therapy for Hematological Cancer Market: Lymphoma (2021-2026) & ($ millions)
Figure 12. CAR-T Therapy for Hematological Cancer in Multiple Myeloma
Figure 13. Global CAR-T Therapy for Hematological Cancer Market: Multiple Myeloma (2021-2026) & ($ millions)
Figure 14. CAR-T Therapy for Hematological Cancer in Leukemia
Figure 15. Global CAR-T Therapy for Hematological Cancer Market: Leukemia (2021-2026) & ($ millions)
Figure 16. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Application in 2025
Figure 17. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Player in 2025
Figure 18. Global CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Figure 19. Americas CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 20. APAC CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 21. Europe CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size 2021-2026 ($ millions)
Figure 23. Americas CAR-T Therapy for Hematological Cancer Value Market Share by Country in 2025
Figure 24. United States CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Region in 2025
Figure 29. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Figure 30. APAC CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Figure 31. China CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 35. India CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Country in 2025
Figure 38. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Figure 39. Europe CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Figure 40. Germany CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 41. France CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 42. UK CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Market Share by Application (2021-2026)
Figure 48. Egypt CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries CAR-T Therapy for Hematological Cancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 54. APAC CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 55. Europe CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 57. United States CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 58. Canada CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 59. Mexico CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 60. Brazil CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 61. China CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 62. Japan CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 63. Korea CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 65. India CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 66. Australia CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 67. Germany CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 68. France CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 69. UK CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 70. Italy CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 71. Russia CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 72. Egypt CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 73. South Africa CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 74. Israel CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 75. Turkey CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
Figure 76. Global CAR-T Therapy for Hematological Cancer Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global CAR-T Therapy for Hematological Cancer Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries CAR-T Therapy for Hematological Cancer Market Size 2027-2032 ($ millions)
